{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:00:47Z","timestamp":1781614847355,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T00:00:00Z","timestamp":1386115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T00:00:00Z","timestamp":1386115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Patients with systemic lupus erythematosus (SLE) have persistent platelet activation and an increased risk of thrombotic events, which cannot be accounted for by traditional cardiovascular risk factors. Factor (F)XII has a potentially important role in thrombus formation and is triggered by activated platelets. We therefore asked whether the contact system is involved in inflammation and vascular disease (VD) in SLE.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Fibrin clots were incubated with purified FXII or whole blood, and the activation and regulation of FXII were studied. Plasma from SLE patients with (n\u2009=\u200931) or without (n\u2009=\u200938) previous VD and from matched healthy controls (n\u2009=\u200968) were analyzed for the presence of complexes formed between contact system enzymes and antithrombin (AT) or C1 inhibitor (C1INH) and evaluated with regard to clinical data and laboratory parameters.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Fibrin clots elicited FXII activation and acted as co-factors for AT. In clotting plasma, the levels of FXIIa-AT increased, and FXIIa-C1INH decreased. A similar reciprocal relationship existed in SLE patients. FXIIa-AT was elevated in the SLE patients with a history of VD, while the corresponding levels of factor FXIIa-C1INH were significantly decreased. FXIIa-AT correlated strongly with platelet parameters. The odds ratio for VD among the SLE patients was 8.9 if they had low levels of FXIIa-C1INH, 6.1 for those with high levels of FXIIa-AT, and increased to 23.4 for those with both decreased levels of FXIIa-C1INH and increased levels of FXIIa-AT.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Activation of FXII is elicited by fibrin during thrombotic reactions <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>, and fibrin acts as a heparin-like co-factor and regulates AT. Patients with SLE had altered levels of FXIIa-serpin complexes, supporting that the contact system is involved in this disease. FXIIa-serpin complexes are strongly associated with previous VD in SLE patients, suggesting that these complexes are potential biomarkers for monitoring and assessing the risk of thrombotic events in SLE.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4399","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T10:01:25Z","timestamp":1386151285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus"],"prefix":"10.1186","volume":"15","author":[{"given":"Jennie","family":"B\u00e4ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders A","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Nilsson","family":"Ekdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"key":"4066_CR1","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/art.21955","volume":"54","author":"S Bernatsky","year":"2006","unstructured":"Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarc\u00f3n G, Sen\u00e9cal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T: Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 2550-2557. 10.1002\/art.21955.","journal-title":"Arthritis Rheum"},{"key":"4066_CR2","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","volume":"44","author":"JM Esdaile","year":"2001","unstructured":"Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, C\u00f4te R, Grover SA, Fortin PR, Clarke AE, Sen\u00e9cal JL: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001, 44: 2331-2337. 10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I.","journal-title":"Arthritis Rheum"},{"key":"4066_CR3","first-page":"149","volume":"68","author":"OD Ratnoff","year":"1955","unstructured":"Ratnoff OD, Margolius A: Hageman trait: an asymptomatic disorder of blood coagulation. Trans Assoc Am Physicians. 1955, 68: 149-154.","journal-title":"Trans Assoc Am Physicians"},{"key":"4066_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","volume":"202","author":"T Renne","year":"2005","unstructured":"Renne T, Pozgajova M, Gruner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B: Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med. 2005, 202: 271-281. 10.1084\/jem.20050664.","journal-title":"J Exp Med"},{"key":"4066_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0037-1612914","volume":"85","author":"K Joseph","year":"2001","unstructured":"Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP: Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb Haemost. 2001, 85: 119-124.","journal-title":"Thromb Haemost"},{"key":"4066_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0162-3109(99)00136-8","volume":"43","author":"K Joseph","year":"1999","unstructured":"Joseph K, Shibayama Y, Nakazawa Y, Peerschke EI, Ghebrehiwet B, Kaplan AP: Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology. 1999, 43: 203-210. 10.1016\/S0162-3109(99)00136-8.","journal-title":"Immunopharmacology"},{"key":"4066_CR7","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1182\/blood.V99.10.3585","volume":"99","author":"F Mahdi","year":"2002","unstructured":"Mahdi F, Madar ZS, Figueroa CD, Schmaier AH: Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood. 2002, 99: 3585-3596. 10.1182\/blood.V99.10.3585.","journal-title":"Blood"},{"key":"4066_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbrc.2009.10.123","volume":"391","author":"J Back","year":"2010","unstructured":"Back J, Sanchez J, Elgue G, Ekdahl KN, Nilsson B: Activated human platelets induce factor XIIa-mediated contact activation. Biochem Biophys Res Commun. 2010, 391: 11-17. 10.1016\/j.bbrc.2009.10.123.","journal-title":"Biochem Biophys Res Commun"},{"key":"4066_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2141.2004.04858.x","volume":"125","author":"KN Ekdahl","year":"2004","unstructured":"Ekdahl KN, Bengtsson AA, Andersson J, Elgue G, Ronnblom L, Sturfelt G, Nilsson B: Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation. Br J Haematol. 2004, 125: 74-78. 10.1111\/j.1365-2141.2004.04858.x.","journal-title":"Br J Haematol"},{"key":"4066_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2001.03101.x","volume":"115","author":"JE Joseph","year":"2001","unstructured":"Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ: Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol. 2001, 115: 451-459. 10.1046\/j.1365-2141.2001.03101.x.","journal-title":"Br J Haematol"},{"key":"4066_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/08916930108995993","volume":"33","author":"M Nagahama","year":"2001","unstructured":"Nagahama M, Nomura S, Ozaki Y, Yoshimura C, Kagawa H, Fukuhara S: Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity. 2001, 33: 85-94. 10.3109\/08916930108995993.","journal-title":"Autoimmunity"},{"key":"4066_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1172\/JCI36728","volume":"119","author":"K Liu","year":"2009","unstructured":"Liu K, Li QZ, Delgado-Vega AM, Abelson AK, S\u00e1nchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ram\u00f3n E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly RP, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA: Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest. 2009, 119: 911-923. 10.1172\/JCI36728.","journal-title":"J Clin Invest"},{"key":"4066_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1172\/JCI38786","volume":"119","author":"C Ponticelli","year":"2009","unstructured":"Ponticelli C, Meroni PL: Kallikreins and lupus nephritis. J Clin Invest. 2009, 119: 768-771. 10.1172\/JCI38786.","journal-title":"J Clin Invest"},{"key":"4066_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/ard.2006.059022","volume":"66","author":"ML Bertolaccini","year":"2007","unstructured":"Bertolaccini ML, Mepani K, Sanna G, Hughes GR, Khamashta MA: Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Ann Rheum Dis. 2007, 66: 533-536.","journal-title":"Ann Rheum Dis"},{"key":"4066_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1365-2141.2000.02251.x","volume":"110","author":"DW Jones","year":"2000","unstructured":"Jones DW, Gallimore MJ, MacKie IJ, Harris SL, Winter M: Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. Br J Haematol. 2000, 110: 721-726. 10.1046\/j.1365-2141.2000.02251.x.","journal-title":"Br J Haematol"},{"key":"4066_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1160\/TH07-04-0277","volume":"98","author":"U Abildgaard","year":"2007","unstructured":"Abildgaard U: Antithrombin\u2013early prophecies and present challenges. Thromb Haemost. 2007, 98: 97-104.","journal-title":"Thromb Haemost"},{"key":"4066_CR17","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.1016\/j.biomaterials.2009.07.052","volume":"30","author":"J Back","year":"2009","unstructured":"Back J, Lang MH, Elgue G, Kalbitz M, Sanchez J, Ekdahl KN, Nilsson B: Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. Biomaterials. 2009, 30: 6573-6580. 10.1016\/j.biomaterials.2009.07.052.","journal-title":"Biomaterials"},{"key":"4066_CR18","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002\/art.1780251101.","journal-title":"Arthritis Rheum"},{"key":"4066_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A: The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996, 39: 363-369. 10.1002\/art.1780390303.","journal-title":"Arthritis Rheum"},{"key":"4066_CR20","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1182\/blood-2010-03-274605","volume":"116","author":"C Lood","year":"2010","unstructured":"Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M, Truedsson L, Sturfelt G, Erlinge D, Bengtsson AA: Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood. 2010, 116: 1951-1957. 10.1182\/blood-2010-03-274605.","journal-title":"Blood"},{"key":"4066_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0049-3848(97)00310-1","volume":"89","author":"J Sanchez","year":"1998","unstructured":"Sanchez J, Elgue G, Riesenfeld J, Olsson P: Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin. Thromb Res. 1998, 89: 41-50. 10.1016\/S0049-3848(97)00310-1.","journal-title":"Thromb Res"},{"key":"4066_CR22","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1002\/art.1780401212","volume":"40","author":"KN Ekdahl","year":"1997","unstructured":"Ekdahl KN, Ronnblom L, Sturfelt G, Nilsson B: Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis. Arthritis Rheum. 1997, 40: 2178-2186. 10.1002\/art.1780401212.","journal-title":"Arthritis Rheum"},{"key":"4066_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4: 295-306. 10.1111\/j.1538-7836.2006.01753.x.","journal-title":"J Thromb Haemost"},{"key":"4066_CR24","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1182\/blood-2011-03-339572","volume":"118","author":"J Konings","year":"2011","unstructured":"Konings J, Govers-Riemslag JW, Philippou H, Mutch NJ, Borissoff JI, Allan P, Mohan S, Tans G, Ten Cate H, Ariens RA: Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood. 2011, 118: 3942-3951. 10.1182\/blood-2011-03-339572.","journal-title":"Blood"},{"key":"4066_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/107602960300900306","volume":"9","author":"P de Pablo","year":"2003","unstructured":"de Pablo P, Ramirez A, Cortina E, de la Pena A, Zamora J, Izaguirre R, Amigo MC: Increased fibrin polymerization rate in patients with primary antiphospholipid syndrome and systemic lupus erythematosus. Clin Appl Thromb Hemost. 2003, 9: 221-225. 10.1177\/107602960300900306.","journal-title":"Clin Appl Thromb Hemost"},{"key":"4066_CR26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1160\/TH05-05-0310","volume":"95","author":"J Pereira","year":"2006","unstructured":"Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, P\u00e9rez C, S\u00e1ez C, Panes O, Matus V, Mezzano D: Circulating platelet-derived microparticles in systemic lupus erythematosus, Association with increased thrombin generation and procoagulant state. Thromb Haemost. 2006, 95: 94-99.","journal-title":"Thromb Haemost"},{"key":"4066_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/j.1538-7836.2007.02687.x","volume":"5","author":"JW Govers-Riemslag","year":"2007","unstructured":"Govers-Riemslag JW, Smid M, Cooper JA, Bauer KA, Rosenberg RD, Hack CE, Hamulyak K, Spronk HM, Miller GJ, ten Cate H: The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost. 2007, 5: 1896-1903. 10.1111\/j.1538-7836.2007.02687.x.","journal-title":"J Thromb Haemost"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4399\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:06:21Z","timestamp":1728381981000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,4]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["4066"],"URL":"https:\/\/doi.org\/10.1186\/ar4399","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,4]]},"assertion":[{"value":"25 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R206"}}